GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ULTA · Aug 3, 2024

Ulta Beauty, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001558370-24-012542General Corporate
Capex intensity65thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.73% · OPTIONAL · VALID

Operating cash generation50thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

7.82% · OPTIONAL · VALID

Revenue growth20thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

0.88% · CORE · VALID

Gross margin35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

38.33% · CORE · VALID

Operating margin35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

12.90% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History62 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
3.34%
Current
3.73%
Delta
0.39%
Cash Generation Increased
Previous
5.85%
Current
7.82%
Delta
1.97%
Growth Decreased
Previous
3.48%
Current
0.88%
Delta
-2.60%
Margin Decreased
Previous
39.25%
Current
38.33%
Delta
-0.92%
Profitability Decreased
Previous
14.71%
Current
12.90%
Delta
-1.81%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.